"Carcinogenicity Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values.
| Descriptor ID |
D015197
|
| MeSH Number(s) |
E05.940.150
|
| Concept/Terms |
Carcinogenicity Tests- Carcinogenicity Tests
- Carcinogenicity Test
- Test, Carcinogenicity
- Tests, Carcinogenicity
- Carcinogenesis Tests
- Carcinogenesis Test
- Test, Carcinogenesis
- Tests, Carcinogenesis
- Tumorigenicity Tests
- Test, Tumorigenicity
- Tests, Tumorigenicity
- Tumorigenicity Test
- Carcinogenic Potency Tests
- Carcinogenic Potency Test
- Potency Test, Carcinogenic
- Potency Tests, Carcinogenic
- Test, Carcinogenic Potency
- Tests, Carcinogenic Potency
- Carcinogen Tests
- Carcinogen Test
- Test, Carcinogen
- Tests, Carcinogen
- Carcinogenic Activity Tests
- Carcinogenic Activity Test
- Test, Carcinogenic Activity
- Tests, Carcinogenic Activity
|
Below are MeSH descriptors whose meaning is more general than "Carcinogenicity Tests".
Below are MeSH descriptors whose meaning is more specific than "Carcinogenicity Tests".
This graph shows the total number of publications written about "Carcinogenicity Tests" by people in this website by year, and whether "Carcinogenicity Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinogenicity Tests" by people in Profiles.
-
Kari G, Rodeck U, Dicker AP. Zebrafish: an emerging model system for human disease and drug discovery. Clin Pharmacol Ther. 2007 Jul; 82(1):70-80.
-
Hulit J, Lee RJ, Russell RG, Pestell RG. ErbB-2-induced mammary tumor growth: the role of cyclin D1 and p27Kip1. Biochem Pharmacol. 2002 Sep; 64(5-6):827-36.
-
Vecchione A, Ishii H, Baldassarre G, Bassi P, Trapasso F, Alder H, Pagano F, Gomella LG, Croce CM, Baffa R. FEZ1/LZTS1 is down-regulated in high-grade bladder cancer, and its restoration suppresses tumorigenicity in transitional cell carcinoma cells. Am J Pathol. 2002 Apr; 160(4):1345-52.
-
Fredericks WJ, Ayyanathan K, Herlyn M, Friedman JR, Rauscher FJ. An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene. Mol Cell Biol. 2000 Jul; 20(14):5019-31.